To Compare the Effect of Leech Therapy and Purgation Therapy in the Management of Atopic Eczema
Phase 3
- Conditions
- Health Condition 1: L209- Atopic dermatitis, unspecified
- Registration Number
- CTRI/2022/12/047825
- Lead Sponsor
- Dr. POOJA PRATAP GIRI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients of age group between 16-65 years.
2. Lesions not more than 12cm in diameter.
3. Patients having cardinal symptoms like itching, erythema, blackish
discoloration, discharge.
4. Patients who are fit for Jalaukavacharana36 and Virechana
Exclusion Criteria
1. Lesions with secondary infection.
2. Patients on corticosteroids treatment.
3. Patients having systemic disorders, any drug reaction and allergic history.
4. Patients having uncontrolled diabetes.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of effectiveness of Jalaukavacharana in Kandu, Daha, Pidaka, Ruja, Shyavata, Rukshata, Bahustrava, Raji of the subjects in comparison with Virechana with Ichhabhedi rasa in the management of atopic Eczema (Vicharchika).Timepoint: At the end of 31 days.
- Secondary Outcome Measures
Name Time Method 1. Assessment of severity of Atopic eczema on EASI scale. <br/ ><br>2) Assessment of severity of Atopic eczema on the basis of serum cortisol levels.Timepoint: At the end of 31 days.